Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers (Q36160904)

12 August 2017

1 reference

title

Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers (English)

1 reference

12 August 2017

Susan T Vadaparampil

1

1 reference

PubMed ID

15951974

12 August 2017

Mary Ropka

series ordinal

2

1 reference

PubMed ID

15951974

12 August 2017

Michael E Stefanek

series ordinal

3

1 reference

12 August 2017

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

4

1 reference

12 August 2017

2

1 reference

12 August 2017

195-206

1 reference

https://scigraph.springernature.com/pub.10.1007/s10689-004-1446-7

12 August 2017

0 references

cites work

Genetic testing for breast and ovarian cancer risk: the psychosocial issues

1 reference

https://api.crossref.org/works/10.1007%2FS10689-004-1446-7

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-004-1446-7

A SELF-RATING DEPRESSION SCALE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-004-1446-7

Psychological impact of receiving negative BRCA1 mutation test results in Ashkenazim.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-004-1446-7

Predictive genetic testing: psychological factors.

21 January 2018

1 reference

12 December 2020

Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample

1 reference

12 December 2020

Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. Rotterdam/Leiden Genetics Workgroup

1 reference

12 December 2020

The State-Trait Anxiety Inventory: a systematic evaluation.

1 reference

12 December 2020

Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer.

1 reference

12 December 2020

Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer.

1 reference

12 December 2020

Psychosocial issues in cancer genetics: from the laboratory to the public

1 reference

12 December 2020

A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.

1 reference

12 December 2020

Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk

1 reference

12 December 2020

Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.

1 reference

12 December 2020

Psychological consequences of predictive genetic testing: a systematic review

1 reference

12 December 2020

Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study.

1 reference

12 December 2020

A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing

1 reference

12 December 2020

Spiritual faith and genetic testing decisions among high-risk breast cancer probands.

1 reference

12 December 2020

Attitudes toward genetic testing in patients with colorectal cancer

1 reference

12 December 2020

Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families.

1 reference

12 December 2020

The influence of psychological distress on use of genetic testing for cancer risk

1 reference

12 December 2020

Impact of BRCA1 testing on women with cancer: a pilot study

1 reference

12 December 2020

Genetic testing: psychological aspects and implications

1 reference

12 December 2020

Impact of Event Scale: A Measure of Subjective Stress

1 reference

12 December 2020

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

12 December 2020

Impact of Event Scale: psychometric properties.

1 reference

12 December 2020

Identification of the breast cancer susceptibility gene BRCA2

1 reference

12 December 2020

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes

1 reference

12 December 2020

Genes implicated in hereditary breast cancer syndromes

1 reference

12 December 2020

Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.

1 reference

12 December 2020

Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey

1 reference

12 December 2020

Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer

1 reference

12 December 2020

The psychological consequences of offering mutation searching in the family for those at risk of hereditary breast and ovarian cancer--a pilot study.

1 reference

12 December 2020

Utilization of BRCA1/2 genetic testing in the clinical setting: report from a single institution

1 reference

12 December 2020

What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review

1 reference

12 December 2020

AGA technical review on hereditary colorectal cancer and genetic testing.

1 reference

12 December 2020

What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer?

1 reference

12 December 2020

Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs

1 reference

12 December 2020

Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.

1 reference

12 December 2020

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

1 reference

12 December 2020

Attitudes toward colon cancer gene testing: factors predicting test uptake

1 reference

12 December 2020

Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.

1 reference

12 December 2020

Psychological responses to BRCA1 mutation testing: preliminary findings.

1 reference

12 December 2020

Genetic testing in families with hereditary nonpolyposis colon cancer

1 reference

12 December 2020

BRCA1, BRCA2 and breast cancer: a concise clinical review

1 reference

12 December 2020

Motivations and psychosocial impact of genetic testing for HNPCC.

1 reference

12 December 2020

Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates

1 reference

12 December 2020

Genetic susceptibility to non-polyposis colorectal cancer

1 reference

12 December 2020

Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups.

1 reference

12 December 2020

One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).

1 reference

12 December 2020

Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence

1 reference

12 December 2020

A rating scale for depression

1 reference

12 December 2020

What do depression rating scales measure?

1 reference

12 December 2020

10.1007/S10689-004-1446-7

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15951974